We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, September 3rd:
Halozyme Therapeutics (HALO - Free Report) : This biopharmaceutical company which is focused on the development and commercialization of novel treatments for oncology indications by targeting tumor microenvironment, has a Zacks Rank #1 (Strong Buy), and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.5% over the last 60 days.
Halozyme Therapeutics' shares gained 36.2% over the last three month compared with the S&P 500’s gain of 7.5%. The company possesses a Momentum Score of A.
T. Rowe Price (TROW - Free Report) : This global investment management organization which provides a broad array of mutual funds, sub-advisory services and separate account management for individual and institutional investors, retirement plans and financial intermediaries, has a Zacks Rank #1, and witnessed the Zacks Consensus Estimate for its current year earnings increasing 9% over the last 60 days.
Cars.com (CARS - Free Report) : These company which operates an online automotive platform that offers new and used vehicle listings, expert and consumer reviews, research tools and other information, has a Zacks Rank #1, and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.3% over the last 60 days.
Image: Bigstock
Best Momentum Stock to Buy for September 3rd
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, September 3rd:
Halozyme Therapeutics (HALO - Free Report) : This biopharmaceutical company which is focused on the development and commercialization of novel treatments for oncology indications by targeting tumor microenvironment, has a Zacks Rank #1 (Strong Buy), and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.5% over the last 60 days.
Halozyme Therapeutics, Inc. Price and Consensus
Halozyme Therapeutics, Inc. price-consensus-chart | Halozyme Therapeutics, Inc. Quote
Halozyme Therapeutics' shares gained 36.2% over the last three month compared with the S&P 500’s gain of 7.5%. The company possesses a Momentum Score of A.
Halozyme Therapeutics, Inc. Price
Halozyme Therapeutics, Inc. price | Halozyme Therapeutics, Inc. Quote
T. Rowe Price (TROW - Free Report) : This global investment management organization which provides a broad array of mutual funds, sub-advisory services and separate account management for individual and institutional investors, retirement plans and financial intermediaries, has a Zacks Rank #1, and witnessed the Zacks Consensus Estimate for its current year earnings increasing 9% over the last 60 days.
T. Rowe Price Group, Inc. Price and Consensus
T. Rowe Price Group, Inc. price-consensus-chart | T. Rowe Price Group, Inc. Quote
T. Rowe Price’s shares gained 14.2% over the last three month compared with the S&P 500’s gain of 7.5%. The company possesses a Momentum Score of A.
T. Rowe Price Group, Inc. Price
T. Rowe Price Group, Inc. price | T. Rowe Price Group, Inc. Quote
Cars.com (CARS - Free Report) : These company which operates an online automotive platform that offers new and used vehicle listings, expert and consumer reviews, research tools and other information, has a Zacks Rank #1, and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.3% over the last 60 days.
Cars.com Inc. Price and Consensus
Cars.com Inc. price-consensus-chart | Cars.com Inc. Quote
Cars.com’s shares gained 22.3% over the last three month compared with the S&P 500’s gain of 7.5%. The company possesses a Momentum Score of A.
Cars.com Inc. Price
Cars.com Inc. price | Cars.com Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.